These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 23868009)
1. Exposure to bisphosphonates and risk of common non-gastrointestinal cancers: series of nested case-control studies using two primary-care databases. Vinogradova Y; Coupland C; Hippisley-Cox J Br J Cancer; 2013 Aug; 109(3):795-806. PubMed ID: 23868009 [TBL] [Abstract][Full Text] [Related]
2. Exposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data. Vinogradova Y; Coupland C; Hippisley-Cox J BMJ; 2013 Jan; 346():f114. PubMed ID: 23325866 [TBL] [Abstract][Full Text] [Related]
3. Exposure to oral bisphosphonates and risk of cancer. Cardwell CR; Abnet CC; Veal P; Hughes CM; Cantwell MM; Murray LJ Int J Cancer; 2012 Sep; 131(5):E717-25. PubMed ID: 22161552 [TBL] [Abstract][Full Text] [Related]
4. Risk of cardiac valvulopathy with use of bisphosphonates: a population-based, multi-country case-control study. Coloma PM; de Ridder M; Bezemer I; Herings RM; Gini R; Pecchioli S; Scotti L; Rijnbeek P; Mosseveld M; van der Lei J; Trifirò G; Sturkenboom M; Osteoporos Int; 2016 May; 27(5):1857-67. PubMed ID: 26694594 [TBL] [Abstract][Full Text] [Related]
5. Oral Bisphosphonates and Upper Gastrointestinal Cancer Risks in Asians with Osteoporosis: A Nested Case-Control Study Using National Retrospective Cohort Sample Data from Korea. Jung SY; Sohn HS; Park EJ; Suh HS; Park JW; Kwon JW PLoS One; 2016; 11(3):e0150531. PubMed ID: 26937968 [TBL] [Abstract][Full Text] [Related]
6. Bisphosphonate use and gastrointestinal tract cancer risk: meta-analysis of observational studies. Oh YH; Yoon C; Park SM World J Gastroenterol; 2012 Oct; 18(40):5779-88. PubMed ID: 23155320 [TBL] [Abstract][Full Text] [Related]
7. Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. Vinogradova Y; Coupland C; Hippisley-Cox J BMJ; 2015 May; 350():h2135. PubMed ID: 26013557 [TBL] [Abstract][Full Text] [Related]
8. Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort. Green J; Czanner G; Reeves G; Watson J; Wise L; Beral V BMJ; 2010 Sep; 341():c4444. PubMed ID: 20813820 [TBL] [Abstract][Full Text] [Related]
9. Bisphosphonate therapy start may transiently increase the risk of tendon rupture in patients with glucocorticoid co-medication: a population-based observational study. Spoendlin J; Meier C; Jick SS; Meier CR Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1116-1123. PubMed ID: 27297005 [TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates and risk of upper gastrointestinal cancer--a case control study using the General Practice Research Database (GPRD). Wright E; Schofield PT; Seed P; Molokhia M PLoS One; 2012; 7(10):e47616. PubMed ID: 23112825 [TBL] [Abstract][Full Text] [Related]
11. Use of menopausal hormone therapy and risk of dementia: nested case-control studies using QResearch and CPRD databases. Vinogradova Y; Dening T; Hippisley-Cox J; Taylor L; Moore M; Coupland C BMJ; 2021 Sep; 374():n2182. PubMed ID: 34588168 [TBL] [Abstract][Full Text] [Related]
15. Risk of atrial fibrillation among bisphosphonate users: a multicenter, population-based, Italian study. Herrera L; Leal I; Lapi F; Schuemie M; Arcoraci V; Cipriani F; Sessa E; Vaccheri A; Piccinni C; Staniscia T; Vestri A; Di Bari M; Corrao G; Zambon A; Gregori D; Carle F; Sturkenboom M; Mazzaglia G; Trifiro G Osteoporos Int; 2015 May; 26(5):1499-506. PubMed ID: 25752621 [TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancer. Monsees GM; Malone KE; Tang MT; Newcomb PA; Li CI J Natl Cancer Inst; 2011 Dec; 103(23):1752-60. PubMed ID: 22021667 [TBL] [Abstract][Full Text] [Related]
17. Oral bisphosphonate use increases the risk for inflammatory jaw disease: a cohort study. Vestergaard P; Schwartz K; Rejnmark L; Mosekilde L; Pinholt EM J Oral Maxillofac Surg; 2012 Apr; 70(4):821-9. PubMed ID: 21764202 [TBL] [Abstract][Full Text] [Related]
18. Exposure to bisphosphonates and risk of cancer: a protocol for nested case-control studies using the QResearch primary care database. Vinogradova Y; Coupland C; Hippisley-Cox J BMJ Open; 2012; 2(1):e000548. PubMed ID: 22240651 [TBL] [Abstract][Full Text] [Related]
19. The impact of dosing frequency on compliance and persistence with bisphosphonates among postmenopausal women in the UK: evidence from three databases. Brankin E; Walker M; Lynch N; Aspray T; Lis Y; Cowell W Curr Med Res Opin; 2006 Jul; 22(7):1249-56. PubMed ID: 16834823 [TBL] [Abstract][Full Text] [Related]
20. Use of oral bisphosphonates and risk of venous thromboembolism: a population-based case-control study. Lamberg AL; Horvath-Puho E; Christensen S; Sørensen HT Osteoporos Int; 2010 Nov; 21(11):1911-7. PubMed ID: 19997902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]